Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association

Cited by (309)

Items 201–300 of 309

1. Safe Reinforcement Learning with Contextual Information: Theory and Application to Comorbidity Management
   Junyu Cao, Esmaeil Keyvanshokooh, Tian Liu · 2023 · SSRN Electronic Journal
2. Substantial Impact of Eicosapentaenoic Acid on Cardiovascular Outcomes in the REDUCE-IT Trial
   Deepak L. Bhatt · 2022 · CardioMetabolic Syndrome Journal
3. EFFECTS OF TRANSPLANTATION OF MSCS AND PANCREATIC BETA CELLS ON METABOLIC PARAMETERS OF BLOOD PLASMA IN RATS WITH MYOCARDIAL INFARCTION WITH UNDERLYING DIABETES MELLITUS
   Vyacheslav Mykhaylichenko, Andrey Pilipchuk, Nadezhda Bondarenko, Dmitry Parshin, А Г Бутырский, Yu. D. Kostyamin, Галина Пучкина · 2022 · Archiv Euromedica
4. Bifurcation strategies using second-generation drug-eluting stents on clinical outcomes in diabetic patients
   Jung‐Joon Cha, Soon Jun Hong, Ju Hyeon Kim, Subin Lim, Hyung Joon Joo, Jae Hyoung Park, Cheol Woong Yu, Jeehoon Kang, Hyo-Soo Kim, Hyeon‐Cheol Gwon et al. · 2022 · Frontiers in Cardiovascular Medicine
5. Correlation between VCAM-1 Level and Absolute Monocyte Count in Coronary Artery Disease
   Anastasha Faustine, Andreas Arie Setiawan, Dwi Retnoningrum, Ariosta Ariosta · 2024 · INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
6. Risk factors for mortality among people with diabetes in Spain: The DIMORTES study
   Elena Caride-Miana, Domingo Orozco‐Beltrán, José A. Quesada, José Joaquín Mira · 2024 · Primary care diabetes
7. Routine stress testing in diabetic patients after coronary intervention: a systematic review and meta-analysis
   Juan Peres de Oliveira, Franciani Rodrigues da Rocha, Ramon Huntermann, Raissa P. de Oliveira, Caroline de Oliveira Fischer Bacca · 2024 · Current Problems in Cardiology
8. Circulating leptin and resistin levels in myocardial infarction patients with insulin resistance
   Ayed A. Dera · 2025 · Journal of International Medical Research
9. De-Escalation Dual Antiplatelet Strategy in Stabilized Myocardial Infarction Patients With Diabetes Mellitus
   Sang Hyun Kim, Kwan Yong Lee, Jaeho Byeon, Jaehyuk Jang, Byung‐Hee Hwang, Eun Ho Choo, Sungmin Lim, Myunhee Lee, Chan Joon Kim, Ik Jun Choi et al. · 2025 · JACC: Cardiovascular Interventions
10. Co-occurrence patterns and related risk factors of ischemic heart disease and type 2 diabetes in burden of disability-adjusted life years among people aged 55 years and older across 203 countries and territories
    Yuting Luo, Xiaohan Qiu, Ben Hu, Haozhong Sun, Yuwei Wang, Ke Meng, Jun Gu, Likun Ma, Jing Zhang · 2025 · Frontiers in Endocrinology
11. Intravascular brachytherapy vs. drug-coated balloons for in-stent restenosis in patients with diabetes
    Gal Sella, Gera Gandelman, Alex Blatt, J G George, Haitham Abu Khadija, Omar Ayyad, Devin Olek, Bin Sing Teh, Yueh-Yun Lin, Anshuj Deva et al. · 2026 · Frontiers in Cardiovascular Medicine
12. Physical Therapist Management of Cardiovascular Diseases
    Ahmed Salah Ahmed, Joseph Abiodun Balogun, Omotayo Iyamide Balogun · 2026 · Springer eBooks
13. Prognostic Utility of the Cytokine Profile for Predicting Major Adverse Cardiovascular Events in Acute Myocardial Infarction Following Percutaneous Coronary Intervention
    Juan Yang, Bo Zhang, Ling Li, Yu Rong Wu, Yanjun Lu · 2026 · International Journal of General Medicine
14. Principles of Diabetes Care and Lifestyle Modification
    Min Kyong Moon · 2021 · Stroke revisited
15. Factors associated with re-hospitalization and status of risk factors among patients with stable coronary artery disease referred to Medical therapy: Unmatched cohort study
    Majid Davari, Mende Mensa Sorato, Behzad Fatemi, Soheila Rezaei, Parham Sadeghipour, Abbas Kebriaeezadeh, Fatemeh Soleymani · 2021 · Iranian Red Crescent Medical Journal
16. Glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus
    О. Е. Супрун, Andrey E. Bagriy, E. S. Mykhailichenko, M. Krivushcheva · 2022 · Clinical pharmacology and therapy
17. Intracoronary artery retrograde thrombolysis combined with percutaneous coronary interventions for ST-segment elevation myocardial infarction complicated with diabetes mellitus: A case report and literature review
    Mingzhi Shen, Yichao Liao, Jian Wang, Xinger Zhou, Yuting Guo, Yingqiao Nong, Yi Guo, Haihui Lu, Rongjie Jin, Jihang Wang et al. · 2022 · Frontiers in Cardiovascular Medicine
18. An Evidence-Based Review of Diabetes Care: History, Types, Relationship to Cancer and Heart Disease, Co-Morbid Factors, and Preventive Measures
    Umesh Chandra Gupta, Subhas Chandra Gupta, Shayle Sugandh Gupta · 2022 · Current Nutrition & Food Science
19. Long-term Effects of Nicorandil Combined with Dihydropyridine Calcium Channel Blockers on Cardiovascular Outcomes in Patients with Coronary Heart Disease: A Real-world Observational Study
    Jia Rong Cheng, Zixuan Zhang, Hongyang Shu, Weijian Hang, Qingqing Zhao, Jinzhao Zhao, Zhichao Xiao, Ning Zhou · 2023 · Cardiovascular Innovations and Applications
20. The Effects of Auricular Therapy in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Hyejin Lee, Bomi Kim, Hyojung Park · 2023 · Journal of Korean Academy of Fundamentals of Nursing
21. Comparison of Post PCI TIMI Flow Between Diabetic and Non-Diabetic Individuals
    Abdul Basit, Ashraf Abdul Qahir, Yusra, Sarfraz Ali Mangi, Muhammad Naveed Aslam, Vickee Kumar Mamtani · 2024 · Journal of Health and Rehabilitation Research
22. Review of international clinical guidelines for the management of hypertension in patients with diabetes mellitus?
    Ушанова Фатима Омариевна, Tatiana Yu. Demidova, S. V. Panteleeva · 2024 · FOCUS Endocrinology
23. Diabetic Heart Disease: An Intricate Interplay of a Widespread Metabolic Disorder with the Cardiovascular System
    Akalu Srinivas Kamakshi Shriya, Vaishnavi Bharat Pawar, Acsah Annie Paul · 2024 · Current Diabetes Reviews
24. Exploring the causality of appendectomy and ischaemic heart disease: a Mendelian randomization study and meta-analysis
    Shuai Wang, Tao Zhang, Yuanlin Sun, Yiwei Yao, Dongliang Yang, Xueyuan Cao · 2024 · Frontiers in Cardiovascular Medicine
25. Extension studies in revascularization for left main coronary artery disease: considerations for good statistical practice and clinical guidance
    Dylan A. Taylor, Warren A. Skoza, Xavier Rosselló · 2024 · European Heart Journal Acute Cardiovascular Care
26. The Clinical Efficacy of Phytochemical Medicines Containing Tanshinol and Ligustrazine in the Treatment of Stable Angina: A Systematic Review and Meta-Analysis
    Li Gao, Tong Wu, Juan Wang, Zhuoran Xiao, Chunhua Jia, Wei Wang · 2021 · Evidence-based Complementary and Alternative Medicine
27. Diabetes mellitus and cardiovascular risk: an update of the recommendations of the Diabetes and Cardiovascular Disease Working Group of the Spanish Society of Diabetes (SED, 2021)
    F. Arrieta, J. Pedro-botet, P. Iglesias, J. C. Obaya, Laura Montánez, G. Maldonado, A. Becerra, J. Navarro, J. C. Pérez, Romina Petrecca et al. · 2022 · Clínica e Investigación en Arteriosclerosis (English Edition)
28. Effects of Ninjurin 2 Polymorphisms on Susceptibility of Coronary Heart Disease
    Yuping Yan, Xiaoyan Du, Xiaoxi Liu, Jingjie Li, Zichao Xiong, Jiamin Wu, Yao Sun, Gang Tian · 2020 · Research Square
29. Role of Flash Glucose Monitoring System Combined With Insulin Pump in Blood Glucose Treatment of Patients with Type 2 Diabetes Mellitus
    Ping Liu, Ting Zeng, L. Cai, Jinxia Wang, Lian Xue · 2021 · Indian Journal of Pharmaceutical Sciences
30. Optimale medikamentöse Therapie bei Typ‑2-Diabetikern mit einer koronaren Herzerkrankung – Update 2021
    Klaus Edel, Ralf Mootz · 2021 · Zeitschrift für Herz- Thorax- und Gefäßchirurgie
31. Inzulinska rezistenca v perioperativnem obdobju – temelj večdisciplinarnih pobud za pospešeno okrevanje po posegu v srčnožilni kirurgiji
    Špela Volčanšek, Juš Kšela · 2021 · Slovenian Medical Journal
32. Cardiovascular Disease and Diabetic Kidney Disease
    Keith C. Ferdinand, Samar A. Nasser, Ayan Ali · 2022 · Springer eBooks
33. The Potential of Rosuvastatin in Stabilizing Lipid Profile and Improving Clinical Outcomes in Covid-19 Patients with Coronary Heart Disease
    William Suciangto, Haerani Rasyid, Nada Indira Ramadhani Nasrum, Muhammad Zaki Rahmani · 2021 · Nusantara Medical Science Journal
34. Association between remnant cholesterol and prediabetes and diabetes : a study based on coronary heart disease angina pectoris population
    Yang Wang, Yijia Liu, Rongrong Yang, Zhu Li, Jinyu Su, Tong Yang, Mei Ma, Guangwei Pan, Xianliang Wang, Lin Li et al. · 2022 · Research Square
35. The Relationship between Body Mass Index and the Pervasiveness of Ischemic Heart Disease in Patients with Type 2 Diabetes
    Shah Zeb, Nadia Shah, Muhammad Ikram Shah, Muhammad Iqbal Qasim, Parveen Akhtar, Amir M Khan · 2022 · Pakistan Journal of Medical and Health Sciences
36. ANGINA STABIL
    Wienta Diarsvitri · 2022 · Surabaya Biomedical Journal
37. The tour-de-force for reducing cardiovascular disease risk in diabetic patients
    Rodrigo Miguel‐dos‐Santos · 2023 · International Journal of Cardiology
38. Managing Stable Coronary Artery Disease in Diabetes
    Ioannis Koulouridis, Michael T. Johnstone · 2023 · Contemporary cardiology
39. EPA and Mixed Omega-3 Fatty Acids: Impact on Dyslipidemia and Cardiovascular Events in Patients with Diabetes
    Om P. Ganda, Robert S. Busch, John R Nelson, Sephy Philip · 2023 · Contemporary diabetes
40. Fibrate Therapy: Impact on Dyslipidemia and Cardiovascular Events in Patients with Diabetes Mellitus Type 2
    Eliot A. Brinton, Vishnu Priya Pulipati · 2023 · Contemporary diabetes
41. Study of Lipid Profiles Levels and Some Parameters of Glucose Monitoring As Predictive Indicators of Recurrent MI in Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)
    Rasha Hasan Jasim, Ahssan Ali Lefta · 2023 · Journal of Kufa for Chemical Sciences
42. Nomogram predicting long-term cardiac mortality in diabetic patients with coronary artery disease
    Fengyi Yu, Zhiyu Liu, Yan Lv, Yunzhe Wang, Junnan Tang, Jinying Zhang · 2023 · Research Square
43. Cystatin C to Left Ventricular Ejection Fraction Ratio as a Novel Predictor of Adverse Outcomes in Patients with Coronary Artery Disease: A Prospective Cohort Study
    Yi Ning, Kai-Yang Wang, Xuan Min, Xian‐Geng Hou, Tingting Wu, Yi‐Tong Ma, Xiang Xie · 2023 · Reviews in Cardiovascular Medicine
44. SYNERGISTIC EFFECT OF FRUITS EXTRACTS OF Balanites aeqyptiaca AND Adansonia digitata ON LIPIDERMIC PARAMETERS OF DIABETICS ALBINO RAT
    Baba Gabi, Hauwa Umar, Hauwa Haruna, Aminu Ado · 2023 · FUDMA Journal of Sciences
45. Comparison of short-term outcomes between patients with extracranial carotid and/or intracranial atherosclerotic disease
    Benjamin Yong‐Qiang Tan, Yilong Zheng, Mervyn Jun Rui Lim, Ying Ying Koh, Ying Kiat Tan, Claire X. Y. Goh, May Zin Myint, Ching‐Hui Sia, Jaclyn Tan, Faimee Erwan Muhamat Nor et al. · 2023 · Clinical Neurology and Neurosurgery
46. PREVALENCE OF DIABETES MELLITUS IN INDIVIDUALS DIAGNOSED WITH CORONARY ARTERY DISEASE (CAD) AND ITS ASSOCIATION WITH SITE OF ATHEROSCLEROTIC LESIONS
    Dr. Saleem Ullah, Dr. Syed Javaid Iqbal, Dr. Hassan Javed, Awais Hussain Kazim, Suleman Khan, Abdul Wadood Kakar · 2024
47. Prognostic Implications of Coronary Artery Sclerosis in Troponin-Positive Patients with Non-Obstructive Coronary Arteries
    Fabienne Kreimer, Clara Schlettert, Mohammad Abumayyaleh, İbrahim Akın, Daniel Materzok, Michael Gotzmann, Fabian Schiedat, Harilaos Bogossian, Mido Max Hijazi, Nazha Hamdani et al. · 2024 · Cardiology and Therapy
48. The Complexity of Premature Coronary Artery Disease
    Nikhen Noverike, Anna Fuji Rahimah, Mohammad Saifur Rohman · 2024 · Heart Science Journal
49. Managing Heart Disease in Persons with Diabetes
    Deborah L. McCrea · 2024 · Critical Care Nursing Clinics of North America
50. Upregulation of circ-0069561 promotes diabetic kidney disease progression
    Chao‐Yi Chen, Xinran Liu, Sai Zhu, Xueqi Liu, Yukai Wang, Yu Ma, Ziyun Hu, Yonggui Wu, Ling Jiang · 2024 · Research Square
51. Features of isolated systolic and resistant arterial hypertension in patients with type 2 diabetes mellitus
    Г. А. Игнатенко, Andrey E. Bagriy, Приколота Алина Вадимовна, О. А. Приколота, Е. С. Михайличенко, И. А. Аршавская, K. Kotova · 2024 · Vrach
52. Uptake of novel evidence-based therapies in patients with type 2 diabetes after a cardiovascular event: insights from CANHEART
    Wade Thompson, Brendan Wong, Atul Sivaswamy, Laura Legere, Douglas S. Lee, Husam Mohamed Abdel-Qadir, Dennis T. Ko, Alanna Weisman, Sheldon W. Tobe, Cynthia Anne Jackevicius et al. · 2025 · CJC Open
53. Impact of Diabetes on Long‐Term Outcomes of Percutaneous Coronary Intervention for Coronary Bifurcation Lesions
    Subin Lim, Soon Jun Hong, Ju Hyeon Kim, Jung‐Joon Cha, Hyung Joon Joo, Jae Hyoung Park, Cheol Woong Yu, Do‐Sun Lim, Chang‐Wook Nam, the COBIS III investigators · 2025 · Catheterization and Cardiovascular Interventions
54. Modelo para predecir riesgo de fallecimiento de causa cardíaca según características clínicas y parámetros del gated-SPECT de perfusión miocárdica
    G. Rodríguez Cabalé, E. Rodríguez Cabalé, Virginia Pubul Núñez, Á. Ruibal · 2025 · Revista Española de Medicina Nuclear e Imagen Molecular
55. Model to predict the risk of cardiac death based on clinical characteristics and Gated-SPECT parameters
    Grethel Rodríguez Cabalé, E. Rodríguez Cabalé, Virginia Pubul Núñez, Á. Ruibal · 2025 · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
56. ABORDAGEM INTERVENCIONISTA OU CIRÚRGICA? DESAFIOS DA REVASCULARIZAÇÃO CORONÁRIA NO PACIENTE DIABÉTICO
    Eder Voltolini · 2025 · EPITAYA eBooks
57. Intoxicación por betabloqueadores
    Universidad de Antioquia, Manuel Alejandro Berbeo, Julián Ríos Murillo, Universidad de Antioquia, Ana María Osorio, Universidad de Antioquia, Juliana Arango, Universidad de Antioquia · 2025
58. Маркери серцевої недостатності, пов’язані з умовами пролонгованого стресу, та можливості їх корекції сучасними цукрознижувальними препаратами
    Наталія Миколаївна Кушнарьова · 2024 · Endokrynologia
59. Management of Symptomatic Patients with Chronic Coronary Syndromes: A Case-based Review on the Role of Ranolazine
    Kok Han Chee, Jordan Bakhriansyah, Rossana Barack, Thoranis Chantrarat, María Elena Camejo Nieves, Maita S Senadrin, Mugilan Sundarajoo, Wanwarang Wongcharoen, Bambang Widyantoro, Radhika Mehta et al. · 2025 · Journal of Asian Pacific Society of Cardiology
60. Effects of Additional Chinese Herbal Medicines Treatment in Patients with Type 2 Diabetes Mellitus Combined with Stable Angina Pectoris: A Retrospective Cohort Study
    Xunjia Xu, Yin Pu Shi, Huijuan Liu, Ruixia Zhao, Weifeng Cui, Mingyi Shao, Haibin Yu, Shuxun Yan, Yu Fu · 2025 · Diabetes Metabolic Syndrome and Obesity
61. Postoperative bleeding in coronary surgery: any differences associated with sex?
    Andréa Cristina Oliveira Freitas, Pedro Jose Correia Ferraz, Pedro Borghesi Poltronieri, Bruna Vendrasco · 2025 · Indian Journal of Thoracic and Cardiovascular Surgery
62. Effectiveness and use of evidence-based cardiovascular preventive therapies in type 2 diabetes patients with established or high risk of atherosclerotic cardiovascular disease
    Jian-Qing Tian, Yuhao Lin, Zhi-Jun Zhang, Yi-Ting Peng, Jia‐Wen Ye, Zhiyi Wang · 2025 · Frontiers in Endocrinology
63. 2025 Clinical Practice Guidelines for Diabetes: Cardiovascular Risk Management
    Hae Jin Kim · 2025 · Journal of Korean Diabetes
64. Role of routine surveillance stress testing in patients with or without imaging-guided or physiology-guided PCI
    Yeonwoo Choi, Do‐Yoon Kang, Hoyun Kim, Jinho Lee, Sangyong Jo, Jung‐Min Ahn, Na Young Kim, Yong‐Hoon Yoon, Seung‐Ho Hur, Cheol Hyun Lee et al. · 2025 · Heart
65. Plasma ALKAL2 levels are associated with coronary atherosclerosis in patients with type 2 diabetes mellitus
    Yipaerguli Maimati, Minhui Wang, Shuai Chen, Feifei Li, Jingmeng Liu, Xinrui Wu, Jianjun Chen, Qiujing Chen, Weifeng Shen, Fenghua Ding et al. · 2025 · Cardiovascular Diabetology
66. Traditional and Virtual Cardiac Rehabilitation: Understanding the Changing Landscape of Cardiac Rehabilitation and the Implications on Patient Outcomes
    Sri Nuvvula, Adrian C. Chen, Amgad N. Makaryus · 2025 · Reviews in Cardiovascular Medicine
67. Design and rationale of the artificial intelligent dialogue System assisted comprehensive Management of secondary prevention Among post coronary aRtery bypass graft patienTs (SMART): protocol for a randomised controlled trial for postcoronary artery bypass grafting management
    Lubi Lei, Jingkuo Li, Lihua Zhang, Xin Yuan, Xiaolin Diao, Le Qi, Yiyi Wang, Wei Du, Wei Zhao, Shengshou Hu · 2025 · BMJ Open
68. Cardiovascular Disease and Risk Management
    2025 · American Diabetes Association eBooks
69. Additional file 3 of Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran Lipid and Glucose Study
    Seyyed Saeed Moazzeni, Hizomi Arani, Reyhane, Deravi, Niloofar, Mitra Hasheminia, Khalili, Davood, Azizi, Fereidoun, Farzad Hadaegh · 2021 · Figshare
70. Additional file 3 of Characterizing the metabolic divide: distinctive metabolites differentiating CAD-T2DM from CAD patients
    Liu, Yingjian, Liu, Ju-e, He, Huafeng, Min Qin, Lei, Heping, Meng, Jinxiu, Liu, Chen, Chen, Xiaoping, Luo, Wenwei, Shilong Zhong · 2024 · Figshare
71. Additional file 4 of An elevated triglyceride-glucose index predicts adverse outcomes and interacts with the treatment strategy in patients with three-vessel disease
    Zhang, Yu, Zhang, Ce, Jiang, Lin, Xu, Lianjun, Jian Tian, Zhao, Xueyan, Wang, Dong, Zhang, Yin, Sun, Kai, Zhang, Channa et al. · 2024 · Figshare
72. Additional file 1 of An elevated triglyceride-glucose index predicts adverse outcomes and interacts with the treatment strategy in patients with three-vessel disease
    Zhang, Yu, Zhang, Ce, L Jiang, Xu, Lianjun, Jian Tian, Zhao, Xueyan, Wang, Dong, Zhang, Yin, Sun, Kai, Zhang, Channa et al. · 2023 · Figshare
73. Additional file 1 of Triglyceride glucose index for the detection of the severity of coronary artery disease in different glucose metabolic states in patients with coronary heart disease: a RCSCD-TCM study in China
    Jinyu Su, Li, Zhu, Mengnan Huang, Wang, Yang, Tong Yang, Ma, Mei, Tongyao Ni, Guangwei Pan, Ziqin Lai, Chunjie Li et al. · 2022 · Figshare
74. Additional file 1 of Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran Lipid and Glucose Study
    Seyyed Saeed Moazzeni, Hizomi Arani, Reyhane, Deravi, Niloofar, Mitra Hasheminia, Khalili, Davood, Azizi, Fereidoun, Farzad Hadaegh · 2021 · Figshare
75. Additional file 2 of An elevated triglyceride-glucose index predicts adverse outcomes and interacts with the treatment strategy in patients with three-vessel disease
    Zhang, Yu, Zhang, Ce, Jiang, Lin, Xu, Lianjun, Jian Tian, Zhao, Xueyan, Wang, Dong, Zhang, Yin, Sun, Kai, Zhang, Channa et al. · 2024 · Figshare
76. Additional file 1 of Effect of glycemic control and glucose fluctuation on in-hospital adverse outcomes after on-pump coronary artery bypass grafting in patients with diabetes: a retrospective study
    You, Hongzhao, Hou, Xiaopei, Zhang, Heng, Li, Xiaojue, Feng, Xinxing, Qian, Xin, Na Shi, Guo, Rong, Wang, Xuan, 孙寒松 et al. · 2024 · Figshare
77. Additional file 1 of Characterizing the metabolic divide: distinctive metabolites differentiating CAD-T2DM from CAD patients
    Liu, Yingjian, Liu, Ju-e, He, Huafeng, Qin, Min, Lei, Heping, Meng, Jinxiu, Liu, Chen, Chen, Xiaoping, Luo, Wenwei, Shilong Zhong · 2024 · Figshare
78. Additional file 2 of Characterizing the metabolic divide: distinctive metabolites differentiating CAD-T2DM from CAD patients
    Liu, Yingjian, Liu, Ju-e, He, Huafeng, Min Qin, Lei, Heping, Meng, Jinxiu, Liu, Chen, Chen, Xiaoping, Luo, Wenwei, Shilong Zhong · 2024 · Figshare
79. Additional file 2 of Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran Lipid and Glucose Study
    Seyyed Saeed Moazzeni, Hizomi Arani, Reyhane, Deravi, Niloofar, Mitra Hasheminia, Khalili, Davood, Azizi, Fereidoun, Farzad Hadaegh · 2021 · Figshare
80. Additional file 3 of An elevated triglyceride-glucose index predicts adverse outcomes and interacts with the treatment strategy in patients with three-vessel disease
    Zhang, Yu, Zhang, Ce, Jiang, Lin, Xu, Lianjun, Jian Tian, Zhao, Xueyan, Wang, Dong, Zhang, Yin, Sun, Kai, Zhang, Channa et al. · 2024 · Figshare
81. Impact of Diabetes on Management and Outcomes in Patients with Borderline FFRCT
    Yan Chen, Zhan Feng, Wenjing Jia, Xiaoyu Ma, Zhengjie He, HaiYue Lou, hongjie hu, Zhen Xian Zhou, Lei Xu · 2025 · Journal of Cardiovascular Development and Disease
82. Contemporary Percutaneous Coronary Intervention in Diabetic Patients
    Francesco Carlo Tartaglia, Gaia Filiberti, Valentina Bernardini, Mauro Gitto, Pier Pasquale Leone, Azeem Latib, Damiano Regazzoli, Giulio Giuseppe Stefanini, Antonio Mangieri, Antonio Colombo · 2025 · Reviews in Cardiovascular Medicine
83. Residual glucose metabolism and Long-Term clinical outcomes in multivessel coronary artery disease: A cohort study
    Aijun You, Mengshi Li, Jianhua Xue, Xi Chen, Qing Zhang, Tianyi Zhu, Liang Zheng, Li Zhang · 2026 · Endocrine
84. Effects of exercise-based cardiac rehabilitation for coronary heart disease combined with diabetes mellitus: a systematic review and meta-analysis
    Meishan Zhang, Jieqiong Zhang, Yinxue Zhang, Weiping Li, Yingqiao Wang, Leyao Han, Jing Su, Yamin Zhang, Xinman Dou, Feng Bai et al. · 2026 · BMC Cardiovascular Disorders
85. Coronary Artery Calcium as a Biological Staging Marker for Atherosclerosis: Aligning Preventive Therapies With Plaque Evolution
    Amogh Jyothi Arun, Bhavika Darji, Victoria Maksymiuk, Madiha Baig, William H. Frishman · 2026 · Cardiology in Review
86. Research Progress on the Relationship between TyG Index, TyG-BMI Index, RDW and the Number and Severity of Coronary Artery Lesions
    麟博 魏 · 2026 · Advances in Clinical Medicine
87. Genetic and clinical risk factors for recurrent events among patients with coronary artery disease
    Jennifer L. Halford, Satoshi Koyama, Yang Sui, So Mi Jemma Cho, Tiffany R. Bellomo, Anika Misra, Aniruddh P. Patel, Whitney Hornsby, Akl C. Fahed, Pradeep Natarajan · 2026 · American Journal of Preventive Cardiology
88. The effect of a polypeptide angioprotector on the rehabilitation of patients with type 2 diabetes mellitus and Atherosclerosis of the arteries of the lower extremities who have suffered myocardial infarction: a prospective controlled trial
    Marta Simonyan, Larisa Marchenkova, Valeriia A. Vasileva · 2026 · Bulletin of Rehabilitation Medicine
89. Framingham Risk Score and Carotid Intima-Media Thickness in Type 2 Diabetes: A Cross-Sectional Study from Urban Indonesia
    Ivan R Richard, Lusiani Lusiani, Dicky L. Tapahary, Arif Mansjoer · 2026 · Tropical Journal of Natural Product Research
90. Pathophysiological pathways linking diabetes to cardiac hypertrophy: From insulin resistance to personalised cardioprotection
    Gaurav Joshi, Nishant Goutam, Shivani Shivani, K. Prasad Kaushal, Abhishashi Sharma, Kaur Harmanbir, Neeraj Joshi · 2026 · Scripta Medica
91. A Systematic Review Evaluating the Impact of Glycemic Control on Mortality and Major Adverse Cardiac Events in Type 2 Diabetic Patients With Acute Coronary Syndrome
    Krishna Adhikari, Asad Ullah, Xu Bing · 2026 · Cureus
92. Multidimensional cardiometabolic protection with SGLT2 inhibitors and GLP-1 receptor agonists in obesity, type 2 diabetes and hypertension
    Renu Vajjiravelu, P. S. Kirtheka, Banuppriya Palani, Santhoshkumar Jayakodi, D. Kirubakaran · 2026 · Obesity Medicine
93. Time-Cumulative Residual Cardiovascular Risk in Patients with Coronary Heart Disease and Diabetes: A 10-Year Follow-Up Study from a Large-Scale Population Cohort and an Independent Clinical Validation Cohort
    Zeping Li, Guangling Li, Yanan Wang, Jialin Zang, Luyun Wang, Jiangang Jiang · 2026 · Journal of Cardiovascular Development and Disease
94. MASLD and Cardiovascular Risk: Mechanisms and Implications for Clinical Practice
    Sainan Li, Michel Toutoungy, Janvi Patel, Indira Bhavsar‐Burke, Lisa B. VanWagner · 2026 · Current Hypertension Reports
95. Glucagon-like peptide-1 receptor agonist versus other anti-diabetic agents on patients with prostate cancer undergoing androgen-deprivation therapy
    Sheng-Chi Huang, Wan-Yu Cheng, Cheng-You Hou, Jheng-Yan Wu, Chih‐Cheng Lai, Wen‐Hsin Tseng · 2026 · Frontiers in Urology
96. Mediterranean lifestyle and risk of adverse cardiovascular events, all-cause and cardiovascular mortality among individuals with type 2 diabetes
    María del Carmen Aznar de la Riera, Jesús Díaz‐Gutiérrez, Stefanos N. Kales, Miguel Ruiz‐Canela, Almudena Castro Conde, Beth Frates, Fernando Rodríguez‐Artalejo, Mercedes Sotos‐Prieto · 2026 · EClinicalMedicine
97. Cardiovascular preventive role of thiazolidinedione in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention
    Jinkwon Kim, Jimin Jeon, Joonsang Yoo, Minyoul Baik, Seok‐Jae Heo, Ji Woong Roh · 2026 · Journal of Diabetes Investigation
98. The Association Between Atherogenic Index of Plasma and Type 2 Diabetes Mellitus in a Multi‐Ethnic Population of Premature Coronary Artery Disease Patients: Insights From IPAD Study
    Reza Amani‐Beni, Ghazal Ghasempour Dabaghi, Noushin Mohammadifard, Ehsan Zarepur, Bahar Darouei, Mehrdad Rabiee Rad, Fahimeh Haghighatdoost, Fatemeh Nouri, Nizal Sarrafzadegan · 2026 · Endocrinology Diabetes & Metabolism
99. Clopidogrel Versus Dual‐Antiplatelet Therapy for Long‐Term Maintenance After Coronary Stenting in Ischemic and Bleeding Birisk Patients With Acute Coronary Syndromes and Diabetes: A Prespecified Subgroup Analysis of the OPT‐BIRISK Trial
    Dali Zhang, Yi Li, Miaohan Qiu, Yujie Zhou, Shao‐Liang Chen, Hanjun Pei, Jinghua Liu, Biao Xu, Yaling Han, Gregg W. Stone · 2026 · Journal of the American Heart Association
100. Targeting Overweight and Obesity Phenotypes for Secondary Prevention of Cardiovascular Disease: A Call to Action for the Middle East and Beyond
     Wael A. Almahmeed, Juan Sebastian Barajas-Gamboa, Mohammad Zubaid, Ebaa Al‐Ozairi, Abdullah Shehab, Khalid Al‐Rasadi, Charbel Abi Khalil, Noor Al Busaidi, Fahad Al Sindi, Zuhier Ahmed Awan et al. · 2026 · Obesity Reviews